Multivariate phase‐dependent optimization of bioprocesses boosts performance and quality—Why timing (of exposure) matters
Biotechnology Progress · 2026-07 · 42 (4)
DOI: 10.1002/btpr.88508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, online erschienen am 17.05.2026. Verfasst von Samuel Kienzle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Global Development CMC Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Batch Cell Culture Techniques. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Applying a single parameter set to describe complex mammalian kinetics often is too simplistic, as it fails to capture sensitive cell‐to‐environment interactions that may be exploited to optimize production performance. To resolve this time dependency, intra‐experimental parameter shifts as part of design of dynamic experiments (DoDE) can be performed to study mammalian growth and production kinetics in fed‐batch processes. This enables growth phase‐dependent optimization, aligned with cellular requirements. Here, we provide a comprehensive, head‐to‐head comparison of our phase‐dependent optimization approach with intra‐experimental shifts of process parameters to a static optimization that retains parameter settings through the entire bioprocess. Showcasing a monoclonal antibody production process development scenario, the study examines growth phase‐dependent effects of temperature (T) and dissolved oxygen (DO) together with time‐invariant parameters for feed and seeding cell density. While the static optimization suggests settings near the center of the design space, phase‐dependent optimization finds an optimum by shifting T and DO between the exponential growth, transition, and production phases. Overall, the phase‐wise optimized process gives an experimentally validated ~30% increase in product titer while maintaining comparable product quality. Furthermore, the approach breaks the correlation between product titer and acidic charged variants: both depend on T but at different timeframes. Additionally, DoDE uncovers a crucial interaction between T and DO, with low T and high DO during the exponential growth phase, leading to strong lactate accumulation. The data demonstrate the advantages of phase‐dependent optimization enabled by DoDE. The results may serve as a good practice example for follow‐up research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Development CMC Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.
- Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany.
- Institute for Stochastics and Applications, University of Stuttgart, Stuttgart, Germany.
- Computational Innovation, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.
ORCID-Profile: Samuel Kienzle
Zitieren
APA
Kienzle, S., Junghans, L., Wittmann, A., Wieschalka, S., Takors, R., Radde, N. E., Presser, B., & Nold, V. (2026). Multivariate phase‐dependent optimization of bioprocesses boosts performance and quality—Why timing (of exposure) matters. Biotechnology Progress, 42(4). https://doi.org/10.1002/btpr.88508
Vancouver
Kienzle S, Junghans L, Wittmann A, Wieschalka S, Takors R, Radde NE, et al. Multivariate phase‐dependent optimization of bioprocesses boosts performance and quality—Why timing (of exposure) matters. Biotechnology Progress. 2026;42(4). doi:10.1002/btpr.88508
BibTeX
@article{Kienzle2026,
author = {Kienzle, Samuel and Junghans, Lisa and Wittmann, Anja and Wieschalka, Stefan and Takors, Ralf and Radde, Nicole Erika and Presser, Beate and Nold, Verena},
title = {Multivariate phase‐dependent optimization of bioprocesses boosts performance and quality—Why timing (of exposure) matters},
journal = {Biotechnology Progress},
year = {2026},
volume = {42},
number = {4},
doi = {10.1002/btpr.88508}
}
EUVIMED